从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.20倍，行业中值32.89倍，ST景峰排名 第95位。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13ST景峰37.2434.6075.3952.70亿行业平均 54.2052.245.62135.79亿行业中值32.8932.712.5764.96亿1新和成9.7911.472.20673.39亿2浙江医药 10.0612.651.33146.84亿3吉林敖东10.6813.250.70205.57亿4华润双鹤12.0612.011.79195.51亿5国药现代 13.1013.471.08145.92亿6辰欣药业14.2613.721.1569.81亿7国邦医药14.2714.561.38113.83亿8华特达因 14.3814.772.4676.13亿9哈药股份14.4315.261.7295.96亿10健康元15.0615.011.42208.19亿11诚意药业 15.5816.602.5733.32亿12丽珠集团15.7415.962.32329.00亿 股东方面，截至2025年3月31日，ST景峰股东户数34311户，较上次减 ...

Company Overview - Hunan Jingfeng Pharmaceutical Co., Ltd. specializes in the research, manufacturing, and sales of pharmaceutical products, with a diverse product line including unique national insurance drugs [2] Financial Performance - For Q1 2025, the company reported revenue of 100 million yuan, a year-on-year decrease of 0.46%, and a net loss of approximately 11.9 million yuan, a significant decline of 960.04% compared to the previous year [3] - The gross profit margin for the company stands at 66.62% [3] Market Position - As of July 3, 2023, the company's stock closed at 5.87 yuan, down 1.34%, with a rolling price-to-earnings (PE) ratio of 36.49 times, compared to the industry average PE of 54.72 times and a median of 33.17 times, placing the company at the 95th position in the industry [1][3] - The total market capitalization of the company is 5.164 billion yuan [1] Shareholding Structure - As of the Q1 2025 report, two institutions hold shares in the company, with a total of 12,476.40 million shares valued at 558 million yuan [1]

7月1日，ST景峰今日收盘6.06元，上涨1.68%，滚动市盈率PE（当前股价与前四季度每股收益总和的比 值）达到37.67倍，总市值53.31亿元。 来源：金融界 从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.81倍，行业中值32.58倍，ST景峰排名 第96位。 资金流向方面，7月1日，ST景峰主力资金净流入970.08万元，近5日总体呈流出状态，5日共流出244.14 万元。 湖南景峰医药股份有限公司的主营业务是医药产品的研发、制造与销售。公司的主要产品是参芎葡萄糖 注射液、心脑宁胶囊（全国独家、国家医保乙类）、盐酸替罗非班注射用浓溶液、盐酸替罗非班氯化钠 注射液、注射用盐酸地尔硫卓和乐脉丸、射用培美曲塞二钠、注射用盐酸吉西他滨、盐酸伊立替康注射 液、注射用磷酸氟达拉滨、注射用奥沙利铂和来曲唑片、璃酸钠注射液（含玻璃酸钠原料药）、镇痛活 络酊（全国独家、国家医保乙类）、通迪胶囊（全国独家）和骨筋丸胶囊、妇平胶囊（全国独家）、金 鸡丸（全国独家）和儿童回春颗粒、注射用泮托拉唑钠、注射用奥美拉唑钠、注射用兰索拉唑、复方胆 通胶囊（国家医保乙类）和消炎利胆胶囊（基药、国家医保甲类）、冰栀伤痛气雾 ...

资金流向方面，6月24日，ST景峰主力资金净流出630.44万元，近5日总体呈流出状态，5日共流出 8514.70万元。 6月24日，ST景峰今日收盘5.8元，上涨1.05%，滚动市盈率PE（当前股价与前四季度每股收益总和的比 值）达到36.05倍，总市值51.03亿元。 从行业市盈率排名来看，公司所处的化学制药行业市盈率平均54.23倍，行业中值30.99倍，ST景峰排名 第96位。 最新一期业绩显示，2025年一季报，公司实现营业收入1.00亿元，同比-0.46%；净利润-11899583.2元， 同比-960.04%，销售毛利率66.62%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13ST景峰36.0533.5072.9951.03亿行业平均 54.2352.415.69132.16亿行业中值30.9931.632.4461.34亿1浙江医药9.5311.991.26139.15亿2新和成 9.6111.262.16660.79亿3吉林敖东10.3212.800.68198.64亿4华润双鹤11.9111.861.77193.02亿5国药现代 12.8113.171.05142.70亿6 ...